These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6192965

  • 1. Interferon: mechanisms of action and clinical value.
    Houglum JE.
    Clin Pharm; 1983; 2(1):20-8. PubMed ID: 6192965
    [Abstract] [Full Text] [Related]

  • 2. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 3. [Update on the use of interferons in clinical practice].
    Lauta VM.
    Clin Ter; 1995; 146(6-7):393-448. PubMed ID: 7586995
    [Abstract] [Full Text] [Related]

  • 4. Interferons in the management of viral hepatitis.
    Zein NN.
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [Abstract] [Full Text] [Related]

  • 5. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S.
    Hepatogastroenterology; 2002 Dec; 49(47):1373-6. PubMed ID: 12239945
    [Abstract] [Full Text] [Related]

  • 6. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 7. [Review of the recent advances on interferon and interferon therapy].
    Doğanay M.
    Mikrobiyol Bul; 1983 Jan; 17(1):69-73. PubMed ID: 6193401
    [Abstract] [Full Text] [Related]

  • 8. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G.
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [Abstract] [Full Text] [Related]

  • 9. Treatment of life-threatening viral infections with interferon alpha: pharmacokinetic studies in a clinical trial.
    Levin S, Hahn T, Rosenberg H, Bino T.
    Isr J Med Sci; 1982 Apr; 18(4):439-46. PubMed ID: 6177663
    [Abstract] [Full Text] [Related]

  • 10. [Possibilities and limits of the use of interferons in the clinic].
    Ludwig CU.
    Schweiz Med Wochenschr; 1989 Nov 04; 119(44):1539-43. PubMed ID: 2479977
    [Abstract] [Full Text] [Related]

  • 11. [The interferon system. A review of biological principles and clinical uses].
    Schneider FJ.
    Z Gesamte Inn Med; 1986 Nov 15; 41(22):613-8. PubMed ID: 2436387
    [Abstract] [Full Text] [Related]

  • 12. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.
    Microsc Res Tech; 2005 Nov 15; 68(3-4):130-48. PubMed ID: 16276514
    [Abstract] [Full Text] [Related]

  • 13. Therapy of acute and chronic viral hepatitis.
    Hoofnagle JH.
    Adv Intern Med; 1994 Nov 15; 39():241-75. PubMed ID: 8140956
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H, Enomoto H, Kishima Y, Yamamoto M, Yoshida K, Okuda Y, Hirotani T, Kuroda T, Ito H, Matsuda M, Terabayashi M, Noguchi S, Kawase I, Nakamura H.
    Hepatogastroenterology; 2003 Nov 15; 50(54):2112-6. PubMed ID: 14696476
    [Abstract] [Full Text] [Related]

  • 15. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S, Thorburn D, Anderloni A, Ardizzone S, Giorgi A, Bianchi Porro G, Parente F.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):209-15. PubMed ID: 16091058
    [Abstract] [Full Text] [Related]

  • 16. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A.
    J Pharmacol; 1983 Aug 01; 14 Suppl 3():105-16. PubMed ID: 6200731
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
    Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP.
    Hepatology; 1996 Oct 01; 24(4):778-89. PubMed ID: 8855176
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.